This leaflet contains a concise overview of the project’s concept and objectives; the presentation of two clinical trials conducted within the project; and highlights the various outputs we will offer to patients and the scientific and medical communities. See the leaflet
All partners attended the 2-day meeting, filled with enthusiasm and collaboration as we planned the first year of the project. Over 2020, we’ll be focused on planning for our two clinical trials: PREV-HAP and TREAT-HAP, which will start in the next year in France, Spain and Greece. We’ll also be setting up the omics studies […]
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847782.
